Clearwater Analytics has announced its agreement to acquire Enfusion, an investment management platform, for $1.5 billion. The deal, supported by an $800 million loan and a $200 million credit line, allows Enfusion shareholders to choose cash, stock, or a combination. Clearwater plans to integrate Enfusion’s technology into its offerings, aiming for a comprehensive investment management solution. With Enfusion reporting significant revenue growth in 2024, this acquisition is seen as a pivotal expansion into the hedge fund industry. Approval from shareholders and regulators is expected before the deal closes in Q2 2025.